Collecting Biomarkers in Pancreatic Cancer
This study is collecting blood samples from people with pancreatic cancer to help future research. We are looking for volunteers who have a known or presumed diagnosis of pancreatic adenocarcinoma (a common type of pancreatic cancer) and are patients at the University of Pennsylvania. The goal is to create a large collection of blood samples that researchers can use to study circulating biomarkers (substances in the blood that can indicate disease). This will help us understand pancreatic cancer better and potentially lead to new ways to diagnose or treat it. The study aims to enroll 30 participants, but its current recruitment status is unclear.
- Study design
- This is an observational study, meaning participants will not receive an experimental treatment. It aims to enroll 30 participants.
- What's involved
- You would provide about 4 tablespoons of blood within a one-week period, and no more than four times within an eight-week period.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your participation would last for an average of one year, or until the study is completed.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Collection of Circulating Biomarkers in Pancreatic Cancer
At a glance
Conditions
NCT05743049
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Abramson Cancer Center at University of Pennsylvania
Philadelphia, Pennsylvaniano site contact published
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Mark O'Hara, MD · PRINCIPAL_INVESTIGATOR · Abramson Cancer Center, University of Pennsylvania
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- To create a comprehensive system to collect, catalogue and store blood specimens from subjects with pancreatic cancer for future research use.Through study completion, an average of 1 year